There is no disease so rare
that it does not deserve attention

Caption : Recruiting trial = ; Ongoing trial =

• • FRANCE
  • ILE-DE-FRANCE
  • PARIS
  • 
  • Prevention of cardiovascular complications by beta-bockers (Céliprolol) in Ehlers-Danlos syndrome type 4 (phase IV)
  • CHU Paris Ouest - Hôpital Européen Georges Pompidou
  • Département de pharmacologie - Toxicologie
  • More details